Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases
Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused…
Browsing Tag
Jeffrey Tong
2 posts
Marea Therapeutics Launches with $190 Million to Transform Cardiometabolic Disease Treatment
Key Highlights $190 million in Series A and B financings led by top investors. MAR001 targets ANGPTL4 to…